WHC is still in active development. Read this to understand our approach.
depiction of DBGIVFWFUFKIQN-UHFFFAOYSA-N.svg
isomerdesign

Fenfluramine

Verificar en isomerdesign

pubchem

Fenfluramine

Verificar en pubchem

pubchem

Dexfenfluramine

Verificar en pubchem

drugmap

Fenfluramine

Verificar en drugmap

drugmap

Fenfluramine

Verificar en drugmap

wiki

Dexfenfluramine

Verificar en wiki

wiki

Fenfluramine

Verificar en wiki

wiki

Levofenfluramine

Verificar en wiki

Data

InChI: InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3

Sinónimos: SCHEMBL16215,3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine,Benzeneethanamine, N-ethyl-.alpha.-methyl-3-(trifluoromethyl)-,ZX-008,Fenfluramine d-form,N-Ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine,CHEBI:5000, Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-(9CI),3-(Trifluoromethyl)-N-ethyl-.alpha.-methylphenethylamine,(+)-(S)-N-ETHYL-A-METHYL-M-(TRIFLUOROMETHYL)PHENETHYLAMINE,Prestwick_868, Fenfluramine [INN:BAN],EINECS 207-276-3,Fenfluramine (INN),GTPL4613,N-ETHYL-.ALPHA.-METHYL-M-(TRIFLUOROMETHYL)PHENETHYLAMINE,(+)-Fenfluramine,FENFLURAMINE [MI], Fenfluramine hydrochloride,N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine,Fenfluraminum [INN-Latin], 1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane,ethyl[(2S)-1-[3-(trifluoromethyl)phenyl]propan-2-yl]amine, Adipomin,d-Fenfluramine,Fenfluraminum,N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,Fenfluramine hydrochloride 100 microg/mL in Acetonitrile,DTXSID001025754,Dexfenfluraminum [Latin],J5.760F,NCGC00159473-02,Brabafen, (S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane,N-Ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,L000742, Fenfluramina, N-Ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine,NCGC00247710-01, (S)-Fenfluramine,DL-Fenfluramine,SCHEMBL16706,CHEMBL87493,NCGC00159473-03,CHEBI:439329,Pesos,2-Ethylamino-1-(3-trifluoromethylphenyl)propane, Dexfenfluramine [INN:BAN],NINDS_000980,AC-16024, Dexfenfluramina [Spanish],DSSTox_CID_3044, Ponderex,FENFLURAMINE [INN],Ponderax, Pesos,N-ETHYL-.ALPHA.-METHYL-3-(TRIFLUOROMETHYL)BENZENEETHANAMINE,Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-, Fenfluraminum,DEXFENFLURAN, Redux (TN),Pondimin (Salt/Mix), Ponderax PA,UNII-E35R3G56OV,(S)-(+)-FENFLURAMINE,DEXFENFLURAMINE [INN],Dexfenfluramina,DB00574, Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-(9CI),DSSTox_RID_76850,Rotondin,Adipomin (Salt/Mix),Ponderex (Salt/Mix),(S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,IDI1_000980, N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,(alphaS)-N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine,(S)-Fenfluramine,NSC_65801,Benzeneethanamine, N-ethyl-.alpha.-methyl-3-(trifluoromethyl)-, (S)-,Fenfluramine (-),BRN 4783711,Fenfluramina,Dexfenfluramine [INN:BAN],DEA No. 1670,CAS_16105-77-4,N-Ethyl-1-[3-(trifluoromethyl)phenyl]-2-propanamine #,E35R3G56OV,UNII-2DS058H2CF, Dexfenfluraminum [Latin], 2-Ethylamino-1-(3-trifluoromethylphenyl)propane,Phenethylamine, N-ethyl-alpha-methyl-m-(trifluoromethyl)-,DEXFENFLURAMINE [HSDB], Fenfluraminum [INN-Latin],Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)-Fenfluramine,ZINC294,Phenethylamine, N-ethyl-.alpha.-methyl-m-(trifluoromethyl)-,N-Ethyl-.alpha.-methyl-3-trifluoromethylphenethylamine,ZX008, (2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,FENFLURAMINE [WHO-DD],PDSP2_001403,N-ethyl-1-(3-(trifluoromethyl)phenyl)propan-2-amine,Tox21_111697,Fenfluramine [INN:BAN],Ponderax (TN),NCGC00159473-05,DEXFENFLURAMINE [VANDF], (+)-Fenfluramine,BENZENEETHANAMINE, N-ETHYL-.ALPHA.-METHYL-3-(TRIFLUOROMETHYL)-, (.ALPHA.S)-,DSSTox_GSID_23044,N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine,ethyl({1-[3-(trifluoromethyl)phenyl]propan-2-yl})amine,ip001,Dexfenfluraminum, N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine, Fenfluramine, (+-)-Isomer, Obedrex,KBio1_000980,BDBM84738,(2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine,(.ALPHA.S)-N-ETHYL-.ALPHA.-METHYL-3-(TRIFLUOROMETHYL)BENZENEETHANAMINE, 1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane,D07805,Fenfluramin, D-Fenfluramine,CAS-458-24-2,Dextrofenfluramine,Fenfluramina [DCIT],Obedrex,Z-008,Acino,D07945,DEXFENFLURAMINE [WHO-DD],Z008,3239-44-9,S 5614,2DS058H2CF,J13.711A,Q418928,Dexfenfluramina [Spanish],BDBM85596,fenfluraminehydrochloride,S 768,FENFLURAMINE [VANDF],Ethyl-[1-methyl-2-(3-trifluoromethyl-phenyl)-ethyl]-amine,Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)-(9CI),CHEMBL248702,NSC_3337,PDSP1_001419,FENFLURAMINE [HSDB],N-Ethyl-3-(trifluoromethyl)amphetamine,Q3025599,PDSP1_000695, (+/-)-Fenfluramine hydrochloride,C06996,Ponderax PA,fenfluramine, Adifax, S 768,HSDB 3080,Isolipan,DB01191, 3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine, Isomeride,Phenfluramine,Fenfluramine,CAS_3239-45-0,NCGC00159473-04, Fenfluramine (INN),Fenfluramine (+),Dexfenfluramine (INN),D-(+)-FENFLURAMINE,Phenethylamine, N-ethyl-alpha-methyl-m-(trifluoromethyl)-, (S)-, Dexfenfluramine (INN),Dexfenfluramine, Rotondin,Fenfluramine hydrochloride (Salt/Mix),PHENETHYLAMINE, N-ETHYL-.ALPHA.-METHYL-M-(TRIFLUOROMETHYL)-, (S)-,AKOS011892098,N-Ethyl-.alpha.-methyl-m-(trifluoromethyl)phenethylamine hydrochloride (Salt/Mix),DTXSID4023044,PDSP2_000685,458-24-2,S-768, Fenfluramina [DCIT], D-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine, Levofenfluramine [INN],Fintepla,Pondimin,(+-)-Fenfluramine,Benzeneethanamine,N-ethyl-alpha-methyl-3-(trifluoromethyl)-, N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine,d-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine,FENFLURAMINE D-FORM [MI],1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane,FT-0770401,Adifax,HSDB 7356, Ponderax (TN),DivK1c_000980


Estimated data

Solubilidad: -2.533 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 87.1% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.